# NSN 6505-01-666-0343: Adenosine Injection

NSN 6505-01-666-0343 (also written 6505016660343; NIIN 01-666-0343) is an adenosine injection in Federal Supply Class 6505, Drugs and Biologicals. 4 manufacturer part numbers from 4 suppliers are on record. It was last purchased in Sep 2026.

## Identification

- NSN: 6505-01-666-0343 (6505016660343)
- NIIN: 01-666-0343 (016660343)
- Item name: ADENOSINE INJECTION
- Federal Supply Class: [FSC 6505 Drugs and Biologicals](https://nsnexplorer.com/fsc/6505/)
- Federal Supply Group: [FSG 65](https://nsnexplorer.com/group/65/)
- Acquisition method suffix code: AMSC Z: a commercial, nondevelopmental or off-the-shelf item. (observed 2026-10-10)
- Acquisition method code: 3

## Characteristics

| Code | Requirement | Reply |
| --- | --- | --- |
| AJCN | PROTECTIVE STORAGE FEATURE | CONTROLLED ROOM TEMPERATURE AND DO NOT REFRIGERATE |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | MILLIGRAMS ADENOSINE ACTIVE INGREDIENT 3.0 |
| AKJQ | PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| CQCT | PRIMARY CONTAINER TYPE | SYRINGE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | MILLILITERS 4.0 |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | ADENOSINE 12 MG, 4 ML SYRINGE, 10S |
| FEAT | SPECIAL FEATURES | 3MG/ML ACTIVE INGREDIENT ADENOSINE 4ML PREFILLED SYRINGE; PRESERVATIVE FREE; (12MG/4ML)PG 10'S NEEDLELESS; STORE AT USP CONTROLLED ROOM TEMPERATURE 20 TO 25 DEG C(68 TO 77 DEG F), DO NOT REFRIGERATE; DO NOT FREEZE; FOR RAPID BOLUS INTRAVENOUS USE. |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |

## Part numbers

| Part number | CAGE | Supplier | Source |
| --- | --- | --- | --- |
| 1482108 | 89875 | DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| 6505NCM173708 | 64616 | DEFENSE MEDICAL STANDARDIZATION BOARD | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| NDC25021-0301-68 | 1XUY5 | AMERISOURCEBERGEN DRUG CORP DBA AMERISOURCEBERGEN DRUG CORP | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |
| NDC25021-0301-68 | 4RP13 | SAGENT PHARMACEUTICALS, INC DBA SAGENT PHARMACEUTICALS, INC | [flis](https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/) |

## Contract awards

Newest first.

| Date | Award | Description | Recipient | Amount |
| --- | --- | --- | --- | --- |
| 2026-09-25 | [SPE2DX25D9900/SPE2DP26F013T](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505016660343) | ADENOSINE INJECTION | DMS PHARMACEUTICAL GROUP INC | $1,388.70 |
| 2026-09-25 | [SPE2DX25D9900/SPE2DP26F013V](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505016660343) | ADENOSINE INJECTION | DMS PHARMACEUTICAL GROUP INC | $231.45 |
| 2026-09-25 | [SPE2DX25D9900/SPE2DP26F013W](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505016660343) | ADENOSINE INJECTION | DMS PHARMACEUTICAL GROUP INC | $231.45 |
| 2026-09-25 | [SPE2DX25D9900/SPE2DP26F013Y](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505016660343) | ADENOSINE INJECTION | DMS PHARMACEUTICAL GROUP INC | $231.45 |
| 2026-09-24 | [SPE2DX25D9900/SPE2DP26F012M](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505016660343) | ADENOSINE INJECTION | DMS PHARMACEUTICAL GROUP INC | $231.45 |
| 2026-09-24 | [SPE2DX25D9900/SPE2DP26F012Z](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505016660343) | ADENOSINE INJECTION | DMS PHARMACEUTICAL GROUP INC | $1,388.70 |
| 2026-09-22 | [SPE2DX25D9900/SPE2DP26F006Z](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505016660343) | ADENOSINE INJECTION | DMS PHARMACEUTICAL GROUP INC | $231.45 |
| 2026-09-22 | [SPE2DX25D9900/SPE2DP26F007B](https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505016660343) | ADENOSINE INJECTION | DMS PHARMACEUTICAL GROUP INC | $1,388.70 |

## Sources

- DLA DIBBS RFQs for this NSN: https://www.dibbs.bsm.dla.mil/RFQ/RFQNsn.aspx?value=6505016660343&category=nsn
- DLA DIBBS awards for this NSN: https://www.dibbs.bsm.dla.mil/Awards/AwdRecs.aspx?category=awdnsn&TypeSrch=cq&Value=6505016660343
- AMSC record: https://www.dla.mil/Portals/104/Documents/InformationOperations/LogisticsInformationServices/FOIA/PUBLOG/
- USAspending contract actions (each award above links to its record)
- All data is public U.S. government data; every row above links to its source record where one exists.

Canonical page: https://nsnexplorer.com/nsn/6505-01-666-0343/
JSON: https://nsnexplorer.com/api/nsn/6505-01-666-0343.json